Vertex Pharmaceuticals (VRTX) Return on Sales (2009 - 2026)

Vertex Pharmaceuticals (VRTX) has reported Return on Sales for 18 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Sales came in at 0.0% for Q1 2026 at Vertex Pharmaceuticals, down from 0.0% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q3 2023, with the low at 0.01% in Q2 2024.
• Average Return on Sales over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
• Across the five-year window, Return on Sales slipped 2 bps in 2024 and grew 2 bps in 2025, its largest moves.
• Year by year, Return on Sales stood at 0.0% in 2022, then advanced by 8 bps to 0.0% in 2023, then decreased by 19 bps to 0.0% in 2024, then advanced by 19 bps to 0.0% in 2025, then fell by 8 bps to 0.0% in 2026.
• According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.